MktsMarkets

Syndax Pharmaceuticals, Inc.
NASDAQ: SNDXKey statistics
SNDX News
Stories mentioning SNDX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 64,864 | 68,481 | 45,871 | 37,958 | 20,042 | 7,680 | 12,500 | 3,500 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 58,845 | 78,641 | 56,280 | 62,227 | 61,636 | 65,529 | 70,971 | 48,655 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 99,066 | 131,029 | 103,297 | 107,311 | 103,799 | 104,045 | 102,077 | 77,716 |
| Operating Income (Loss) | (34,202) | (62,548) | (57,426) | (69,353) | (83,757) | (96,365) | (89,577) | (74,216) |
| Interest Income | 3,561 | 4,328 | 5,269 | 5,950 | 7,183 | 7,108 | 5,442 | 6,284 |
| Interest Expense | 45.00 | |||||||
| Other Expense | (186.00) | (275.00) | (221.00) | (106.00) | 32.00 | (86.00) | ||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | ||||||
| Net Income (Loss) | (42,673) | (68,014) | (60,715) | (71,847) | (84,846) | (94,169) | (84,126) | (68,063) |
| Earnings Per Share (Basic) | (0.48) | (0.79) | (0.70) | (0.83) | (0.98) | (1.10) | (0.98) | (0.80) |
| Earnings Per Share (Diluted) | (0.48) | (0.79) | (0.70) | (0.83) | (0.98) | (1.10) | (0.98) | (0.80) |
| Weighted Average Shares Outstanding (Basic) | 88,256 | 86,626 | 86,621 | 86,337 | 86,172 | 85,622 | 85,434 | 85,275 |
| Weighted Average Shares Outstanding (Diluted) | 88,256 | 86,626 | 86,621 | 86,337 | 86,172 | 85,622 | 85,434 | 85,275 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SNDX
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol SNDX. It last traded at $9.55 (Nov 9, 2026, 4:00 PM ET), up 0.1% on the day. That gives Syndax Pharmaceuticals a market capitalisation of $870.1M.
Over the past 52 weeks SNDX has traded between $9.22 and $25.59.
Revenue for the quarter ended Mar 31, 2026 was $64.9M; a net loss of $42.7M. Revenue was up 224% from $20.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $64.9M | -$42.7M | -65.8% |
| Dec 31, 2025 | $68.5M | -$68.0M | -99.3% |
| Sep 30, 2025 | $45.9M | -$60.7M | -132.4% |
| Jun 30, 2025 | $38.0M | -$71.8M | -189.3% |
From Syndax Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…